Med Hypotheses 2005
Saxenda Gastroparesis Lawsuits and Intestinal Blockage Claims Drive Mass Filings By early March 2025, more than 400 plaintiffs had filed Saxenda lawsuits alleging gastroparesis (stomach paralysis), bowel obstruction, intestinal blockage, and related medical conditions requiring hospitalization
Transcriptome analysis reveals the mechanism of stromal cell-derived factor-1 and exendin-4 synergistically promoted periodontal ligament stem cells osteogenic differentiation
However, the choice of copper compound remains important
Evidence ranges from international approvals and randomized trials to preclinical and community-use data
Gantt is now one of thousands of individuals suing Ozempics manufacturer, Novo Nordisk, alleging that the drugs warning labels fail to properly warn patients about side effects related to gastroparesis, ileus, and bowel obstruction